Title : The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinoma.

Pub. Date : 2016 Mar 22

PMID : 26909611






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinoma. abemaciclib cyclin dependent kinase 4 Homo sapiens
2 Here, we report the antiproliferative activity of LY2835219, a selective CDK4/6 inhibitor through inhibition of CDK4/6-dependent Ser780 phosphorylation in retinoblastoma (RB) and induction of cell cycle arrest in HNSCC cells. abemaciclib cyclin dependent kinase 4 Homo sapiens
3 Here, we report the antiproliferative activity of LY2835219, a selective CDK4/6 inhibitor through inhibition of CDK4/6-dependent Ser780 phosphorylation in retinoblastoma (RB) and induction of cell cycle arrest in HNSCC cells. abemaciclib cyclin dependent kinase 4 Homo sapiens